19.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$19.64
Aprire:
$19.75
Volume 24 ore:
5.63M
Relative Volume:
0.68
Capitalizzazione di mercato:
$13.60B
Reddito:
$2.87B
Utile/perdita netta:
$250.10M
Rapporto P/E:
61.89
EPS:
0.3188
Flusso di cassa netto:
$1.13B
1 W Prestazione:
+1.91%
1M Prestazione:
+20.82%
6M Prestazione:
+10.59%
1 anno Prestazione:
+17.30%
Healthpeak Properties Inc Stock (DOC) Company Profile
Nome
Healthpeak Properties Inc
Settore
Industria
Telefono
949-407-0700
Indirizzo
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, CTRE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
DOC
Healthpeak Properties Inc
|
19.73 | 13.54B | 2.87B | 250.10M | 1.13B | 0.3188 |
|
WELL
Welltower Inc
|
216.17 | 152.48B | 11.75B | 1.46B | 2.19B | -0.6014 |
|
VTR
Ventas Inc
|
88.18 | 42.78B | 6.13B | 272.21M | 1.38B | 0.5521 |
|
OHI
Omega Healthcare Investors Inc
|
47.90 | 14.37B | 1.24B | 655.98M | 857.80M | 2.063 |
|
CTRE
Caretrust Reit Inc
|
41.14 | 9.69B | 522.75M | 333.94M | 397.14M | 1.5617 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Iniziato | UBS | Neutral |
| 2026-02-05 | Downgrade | Argus | Buy → Hold |
| 2026-01-09 | Iniziato | Goldman | Neutral |
| 2025-12-16 | Downgrade | Jefferies | Buy → Hold |
| 2025-10-01 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2024-04-26 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Ripresa | Mizuho | Buy |
| 2024-04-01 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-03-25 | Ripresa | Wells Fargo | Equal Weight |
| 2024-03-08 | Ripresa | RBC Capital Mkts | Outperform |
| 2024-01-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-04-20 | Iniziato | Wells Fargo | Underweight |
| 2022-12-14 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Iniziato | JP Morgan | Neutral |
| 2022-08-05 | Downgrade | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Iniziato | CapitalOne | Equal Weight |
| 2022-05-19 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Iniziato | Barclays | Overweight |
| 2022-02-01 | Iniziato | Credit Suisse | Neutral |
| 2022-01-07 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-12-14 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Ripresa | Robert W. Baird | Outperform |
| 2020-09-02 | Ripresa | Stifel | Buy |
| 2020-04-07 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-01 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-03-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-03-09 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Aggiornamento | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Iniziato | Mizuho | Buy |
| 2019-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-11-26 | Aggiornamento | Stifel | Hold → Buy |
| 2019-10-14 | Iniziato | BofA/Merrill | Neutral |
| 2019-06-20 | Iniziato | Citigroup | Neutral |
| 2019-05-02 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Aggiornamento | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Downgrade | Stifel | Buy → Hold |
| 2018-03-01 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Reiterato | Robert W. Baird | Outperform |
| 2017-11-06 | Aggiornamento | Hilliard Lyons | Long-term Buy → Buy |
Mostra tutto
Healthpeak Properties Inc Borsa (DOC) Ultime notizie
Healthpeak Properties stock: Is DOC underperforming the real estate sector? - MSN
Morgan Stanley Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Healthpeak Properties Is Maintained at Overweight by Morgan Stanley - Moomoo
Healthpeak Properties Price Target Raised to $20.00/Share From $18.00 by Morgan Stanley - Moomoo
DOC Maintained by Morgan Stanley -- Price Target Raised to $20 - GuruFocus
Morgan Stanley Adjusts Price Target on Healthpeak Properties to $20 From $18, Maintains Overweight Rating - Moomoo
What is Janus Living and Why is Healthpeak Spinning it Off - Kavout
A Look At Healthpeak Properties (DOC) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Healthpeak’s S&P 500 Rally Raises A Big Valuation Question - Kalkine Media
Analysts Offer Insights on Real Estate Companies: Rayonier (RYN), Weyerhaeuser (WY) and Healthpeak Properties (DOC) - The Globe and Mail
Assessing Healthpeak Properties (DOC) Valuation After Recent Share Price Momentum - simplywall.st
Verizon and 4 More Stocks With 5% Dividend Yields—and Market-Beating Returns - Barron's
Mizuho Securities Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $21 - Moomoo
New York Life Investment Management LLC Boosts Holdings in Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak (DOC) CEO makes 120,372-unit OP equity gifts, retains stake - Stock Titan
How Investors Are Reacting To Healthpeak Properties (DOC) Earnings Upgrade And Completed Share Buyback - simplywall.st
Are Wall Street analysts bullish on Healthpeak Properties stock? - MSN
Verizon and 4 Other Stocks With 5% Yields—and Market-Beating Returns - Barron's
Baird Raises its Price Target on Healthpeak Properties (DOC) - Insider Monkey
Mizuho Adjusts Price Target on Healthpeak Properties to $21 From $18, Maintains Outperform Rating - Moomoo
JAN Stock Price, Quote & Chart | JANUS LIVING INC CL-A-1 (NYSE:JAN) - ChartMill
Healthpeak Properties stock (US42226K1051): analyst moves and solid earnings support 2026 rally - AD HOC NEWS
10 Fastest Growing S&P 500 Stocks to Buy Now - Insider Monkey
Healthpeak Properties, Inc.: - marketscreener.com
Healthpeak Properties Q1 earnings call highlights - MSN
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
BNP Paribas Adjusts PT on Healthpeak Properties to $22 From $21, Maintains Outperform Rating - Moomoo
[SCHEDULE 13G] Janus Living, Inc. Passive Investment Disclosure (>5%) - Stock Titan
DOC Maintained by RBC Capital -- Price Target Raised to $21.00 - GuruFocus
Healthpeak Properties Is Maintained at Outperform by RBC Capital - Moomoo
Healthpeak Properties (NYSE:DOC) Hits New 1-Year High After Analyst Upgrade - MarketBeat
RBC Raises Price Target on Healthpeak Properties to $21 From $20, Keeps Outperform Rating - marketscreener.com
VIRGINIA RETIREMENT SYSTEMS ET Al Has $5.15 Million Position in Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak Properties: A Healthy Balance Sheet And Growth Opportunities Outweigh Risk Concerns - Seeking Alpha
Insider Sell: Scott Bohn Sells Shares of Healthpeak Properties I - GuruFocus
Scott Bohn Sells 10,989 Shares of Healthpeak Properties (NYSE:DOC) Stock - MarketBeat
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Healthpeak (NYSE: DOC) CDO Scott Bohn sells 10,989 shares - Stock Titan
DOC Maintained by UBS -- Price Target Raised to $19.00 - GuruFocus
JPMorgan Chase (DOC) holds 43.09M shares, 6.1% stake in Healthpeak (05/13/2026) - Stock Titan
UBS Raises Healthpeak Properties Price Target to $19 From $17, Neutral Rating Kept - marketscreener.com
DOC Maintained by Baird -- Price Target Raised to $21.00 - GuruFocus
Healthpeak Properties stock (US42226K1051): Baird, Citi and Jefferies raise price targets - AD HOC NEWS
Jefferies Adjusts Price Target on Healthpeak Properties to $19 From $16, Maintains Hold Rating - marketscreener.com
Baird Adjusts Price Target on Healthpeak Properties to $21 From $19, Maintains Outperform Rating - marketscreener.com
Healthpeak Properties: Lab Weakness Creates A Major Re-Rating Opportunity (NYSE:DOC) - Seeking Alpha
DOC Maintained by Citigroup -- Price Target Raised to $20.00 - GuruFocus
[144] HEALTHPEAK PROPERTIES, INC. SEC Filing - Stock Titan
Evercore ISI Downgrades Healthpeak Properties to In Line From Outperform, Adjusts Price Target to $21 From $20 - Moomoo
Citigroup Adjusts PT on Healthpeak Properties to $20 From $17.50, Maintains Neutral Rating - marketscreener.com
Healthpeak Properties Inc Azioni (DOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):